1. Home
  2. RDY vs TECH Comparison

RDY vs TECH Comparison

Compare RDY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • TECH
  • Stock Information
  • Founded
  • RDY 1984
  • TECH 1976
  • Country
  • RDY India
  • TECH United States
  • Employees
  • RDY N/A
  • TECH N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RDY Health Care
  • TECH Health Care
  • Exchange
  • RDY Nasdaq
  • TECH Nasdaq
  • Market Cap
  • RDY 13.1B
  • TECH 11.3B
  • IPO Year
  • RDY N/A
  • TECH 1989
  • Fundamental
  • Price
  • RDY $79.49
  • TECH $69.79
  • Analyst Decision
  • RDY Buy
  • TECH Buy
  • Analyst Count
  • RDY 1
  • TECH 9
  • Target Price
  • RDY $87.00
  • TECH $80.67
  • AVG Volume (30 Days)
  • RDY 156.2K
  • TECH 733.5K
  • Earning Date
  • RDY 10-29-2024
  • TECH 10-30-2024
  • Dividend Yield
  • RDY 1.20%
  • TECH 0.46%
  • EPS Growth
  • RDY 17.48
  • TECH N/A
  • EPS
  • RDY 4.00
  • TECH 1.05
  • Revenue
  • RDY $3,460,984,788.00
  • TECH $1,159,060,000.00
  • Revenue This Year
  • RDY $13.21
  • TECH $6.90
  • Revenue Next Year
  • RDY $8.56
  • TECH $9.69
  • P/E Ratio
  • RDY $19.79
  • TECH $66.62
  • Revenue Growth
  • RDY 10.49
  • TECH 1.97
  • 52 Week Low
  • RDY $63.72
  • TECH $51.79
  • 52 Week High
  • RDY $84.46
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.19
  • TECH 36.63
  • Support Level
  • RDY $78.40
  • TECH $72.16
  • Resistance Level
  • RDY $80.00
  • TECH $75.17
  • Average True Range (ATR)
  • RDY 0.86
  • TECH 1.77
  • MACD
  • RDY 0.11
  • TECH -0.59
  • Stochastic Oscillator
  • RDY 58.28
  • TECH 8.62

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: